This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ling-Hung Wei: Innovator in Monoclonal Antibody Research
Introduction
Ling-Hung Wei is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ling-Hung Wei holds a patent for a monoclonal antibody, which is a crucial development in the treatment and diagnosis of various diseases. This patent highlights his commitment to improving healthcare through innovative solutions. The patent is a testament to his research capabilities and his role in the scientific community.
Career Highlights
Wei is affiliated with National Taiwan University, where he has been involved in various research projects. His work at the university has allowed him to collaborate with other experts in the field, further enhancing his contributions to biotechnology. His career is marked by a focus on developing effective medical treatments and advancing scientific knowledge.
Collaborations
Throughout his career, Ling-Hung Wei has worked alongside notable colleagues such as Kuo-Tai Hua and Min-Wei Chen. These collaborations have enriched his research and have led to significant advancements in their shared field of study.
Conclusion
Ling-Hung Wei is a dedicated inventor whose work in monoclonal antibodies has the potential to impact the medical field significantly. His contributions through patents and collaborations reflect his commitment to innovation and excellence in research.